Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia

CONCLUSION: ETV6::ABL1 is a rare but recurrent genetic aberration in AML, and the combined use of fluorescence in situ hybridization and PCR can better identify this fusion gene. Patients carrying ETV6::ABL1 have a high relapse rate and a poor prognosis. TKIs are a reasonable treatment option for this group, and allo-HSCT may be curative.PMID:38441775 | DOI:10.1007/s12185-024-03729-9

Source: International Journal of Hematology - March 5, 2024 Category: Hematology Authors: Song Xue Hui-Peng Sun Xiao-Bing Huang Xue Chen Tong Wang Wei Ma Yao Tian Zhi-Lan Pan Li-Hong Li Lu Zhang Hong-Xing Liu Xing-Yu Cao Source Type: research